title: The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.
abstract: OBJECTIVE
  Postburn long-term oxandrolone treatment improves hypermetabolism and body composition. The effects of oxandrolone on clinical outcome, body composition, endocrine system, and inflammation during the acute phase postburn in a large prospective randomized single-center trial have not been studied.
  
  
  METHODS
  Burned children (n = 235) with >40% total body surface area burn were randomized (block randomization 4:1) to receive standard burn care (control, n = 190) or standard burn care plus oxandrolone for at least 7 days (oxandrolone 0.1 mg/kg body weight q.12 hours p.o, n = 45). Clinical parameters, body composition, serum hormones, and cytokine expression profiles were measured throughout acute hospitalization. Statistical analysis was performed by Student t test, or ANOVA followed by Bonferroni correction with significance accepted at P < 0.05.
  
  
  RESULTS
  Demographics and clinical data were similar in both groups. Length of intensive care unit stay was significantly decreased in oxandrolone-treated patients (0.48 +/- 0.02 days/% burn) compared with controls (0.56 +/- 0.02 days/% burn), (P < 0.05). Control patients lost 8 +/- 1% of their lean body mass (LBM), whereas oxandrolone-treated patients had preserved LBM (+9 +/- 4%), P < 0.05. Oxandrolone significantly increased serum prealbumin, total protein, testosterone, and AST/ALT, whereas it significantly decreased alpha2-macroglobulin and complement C3, P < 0.05. Oxandrolone did not adversely affect the endocrine and inflammatory response as we found no significant differences in the hormone panels and cytokine expression profiles.
  
  
  CONCLUSIONS
  In this large prospective, double-blinded, randomized single-center study, oxandrolone shortened length of acute hospital stay, maintained LBM, improved body composition and hepatic protein synthesis while having no adverse effects on the endocrine axis postburn, but was associated with an increase in AST and ALT.
authors: Shriners Hospital for Children, and Department of Surgery, University Texas Medical Branch, Galveston, Texas, USA. majeschk@utmb.edu
authors: Marc G
authors: MG
authors: Jeschke
authors: Celeste C
authors: CC
authors: Finnerty
authors: Oscar E
authors: OE
authors: Suman
authors: Gabriela
authors: G
authors: Kulp
authors: Ronald P
authors: RP
authors: Mlcak
authors: David N
authors: DN
authors: Herndon
mesh_terms: D045930:Anabolic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000704:Analysis of Variance; D001823:Body Composition / Q000187:drug effects; D015992:Body Mass Index; D002056:Burns / Q000378:metabolism* / Q000628:therapy; D002153:Calorimetry, Indirect; D016009:Chi-Square Distribution; D002648:Child; D016207:Cytokines / Q000378:metabolism; D004311:Double-Blind Method; D005260:Female; D006728:Hormones / Q000378:metabolism; D006801:Humans; D008297:Male; D008659:Metabolic Diseases / Q000209:etiology / Q000517:prevention & control; D053580:Muscle Strength / Q000187:drug effects; D010074:Oxandrolone / Q000494:pharmacology* / Q000627:therapeutic use; D011446:Prospective Studies; D011506:Proteins / Q000378:metabolism; D018709:Statistics, Nonparametric; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D045930:Anabolic Agents; D016207:Cytokines; D006728:Hormones; D011506:Proteins; D010074:Oxandrolone
references: Crit Care Med. 2001 Jul;29(7):1318-24
references: 11445678
references: J Trauma. 2007 Mar;62(3):676-81
references: 17414346
references: N Engl J Med. 2001 Oct 25;345(17):1223-9
references: 11680441
references: J Pediatr Endocrinol Metab. 2002 Feb;15(2):129-38
references: 11874177
references: Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E172-7
references: 12067858
references: J Burn Care Rehabil. 2002 Jul-Aug;23(4):288-93; discussion 287
references: 12142585
references: Ann Surg. 2003 Mar;237(3):422-8
references: 12616128
references: Lancet Oncol. 2003 Mar;4(3):135
references: 12623350
references: J Appl Physiol (1985). 2003 Jun;94(6):2273-81
references: 12588788
references: Minerva Anestesiol. 2003 Apr;69(4):264-74
references: 12766718
references: J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):267-73
references: 12794565
references: Ann Surg. 2003 Jun;237(6):801-10; discussion 810-1
references: 12796576
references: J Trauma. 2004 Jan;56(1):37-44
references: 14749563
references: J Appl Physiol (1985). 2004 Mar;96(3):1055-62
references: 14578370
references: Drugs. 2004;64(7):725-50
references: 15025546
references: Ann Allergy Asthma Immunol. 2004 Mar;92(3):377-8
references: 15049404
references: Lancet. 2004 Jun 5;363(9424):1895-902
references: 15183630
references: Steroids. 2004 May;69(5):357-66
references: 15219414
references: Burns. 2004 Sep;30(6):565-8
references: 15302422
references: J Clin Endocrinol Metab. 2004 Oct;89(10):4863-72
references: 15472177
references: Ann Surg. 1974 Oct;180(4):653-69
references: 4412350
references: Surg Clin North Am. 1978 Dec;58(6):1173-87
references: 32634
references: J Crit Care. 2000 Mar;15(1):12-7
references: 10757193
references: Pediatr Nephrol. 2000 Apr;14(4):301-4
references: 10775073
references: Wound Repair Regen. 2000 Mar-Apr;8(2):97-102
references: 10810035
references: Ann Med. 2000 Apr;32(3):181-6
references: 10821325
references: Crit Care Med. 2000 May;28(5):1578-84
references: 10834715
references: Mayo Clin Proc. 2000 Jan;75 Suppl:S55-9; discussion S59-60
references: 10959218
references: Ann Surg. 2000 Oct;232(4):455-65
references: 10998644
references: HIV Hotline. 1998 Dec;8(5-6):2-5
references: 11366381
references: Ann Surg. 2001 Apr;233(4):556-64
references: 11303139
references: Br Med Bull. 1985 Jul;41(3):257-64
references: 3896381
references: Arch Surg. 1990 Mar;125(3):392-5
references: 2306187
references: Clin Endocrinol (Oxf). 1993 Apr;38(4):393-8
references: 8319371
references: Arch Surg. 1994 Dec;129(12):1301-4; discussion 1304-5
references: 7986160
references: J Pediatr. 1995 Feb;126(2):252-6
references: 7844672
references: JPEN J Parenter Enteral Nutr. 1995 Jul-Aug;19(4):258-65
references: 8523623
references: Bone. 1995 Nov;17(5):455-60
references: 8579956
references: J Clin Invest. 1996 Jan 15;97(2):339-48
references: 8567953
references: Biochem Soc Trans. 1995 Nov;23(4):1019-25
references: 8654673
references: Horm Res. 1997;48 Suppl 5:83-7
references: 9434050
references: Shock. 1998 Oct;10(4):298-306
references: 9788663
references: Ostomy Wound Manage. 1998 Oct;44(10):58-62, 64, 66 passim
references: 9866597
references: J Clin Endocrinol Metab. 1999 Aug;84(8):2705-11
references: 10443664
references: Curr Opin Clin Nutr Metab Care. 1999 May;2(3):201-5
references: 10456248
references: Ann Surg. 2005 Sep;242(3):384-9, discussion 390-1
references: 16135924
references: J Gerontol A Biol Sci Med Sci. 2005 Dec;60(12):1586-92
references: 16424293
references: J Burn Care Res. 2006 Mar-Apr;27(2):131-9; discussion 140-1
references: 16566555
references: J Trauma. 2006 May;60(5):968-71; discussion 971
references: 16688056
references: Shock. 2006 Jul;26(1):13-9
references: 16783192
references: Ann Surg. 2006 Jul;244(1):121-30
references: 16794397
references: Physiol Res. 2006;55(4):421-8
references: 16238457
references: Shock. 2007 Jan;27(1):4-9
references: 17172973
references: Pediatrics. 2007 Jan;119(1):e109-16
references: 17130281
references: Crit Care Med. 2007 Feb;35(2):579-83
references: 17205022
references: J Appl Physiol (1985). 2001 Sep;91(3):1168-75
references: 11509512